Hospital
Lehigh Valley Hospital - Schuylkill
Lehigh Valley Hospital - Schuylkill was paid $6.83M by Medicaid between Oct 2019 and Dec 2024, across 136 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.
33Billing provider infoLEHIGH VALLEY HOSPITAL - SCHUYLKILL
POTTSVILLE, PA 17901
POTTSVILLE, PA 17901
33aNPI1235138405assigned 07/19/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.83M
24GClaims154,013
24DCodes billed136
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#46 of 154
Median peer was paid$2.82M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMAS, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 292 | $5K | |
| 2020 | 12,337 | $385K | |
| 2021 | 53,351 | $2.11M | |
| 2022 | 27,516 | $1.49M | |
| 2023 | 34,033 | $1.58M | |
| 2024incomplete | 26,484 | $1.26M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 17,998 | 17,413 | $2.62M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 16,104 | 15,558 | $1.75M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.0% | 3,959 | 3,831 | $611K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 3.6% | 6,466 | 1,628 | $245K |
| G0378 | Hospital observation service, per hour | 3.0% | 215 | 177 | $206K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.9% | 2,177 | 2,106 | $199K |
| 80053 | Comprehensive metabolic panel | 1.5% | 12,624 | 11,950 | $105K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 645 | 637 | $96K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.2% | 3,755 | 3,607 | $81K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 1,394 | 1,334 | $81K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 847 | 836 | $65K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,086 | 1,006 | $61K |
124 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,741 | $60K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,940 | $60K |
| X0621 | <1% | 279 | $60K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 512 | $42K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 655 | $39K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,178 | $30K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,119 | $24K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 378 | $24K |
| 84484 | <1% | 2,767 | $22K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 283 | $19K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 288 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 739 | $16K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,277 | $16K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 650 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 465 | $14K |
| 76642 | <1% | 306 | $12K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,416 | $12K |
| 84703 | <1% | 1,411 | $12K | |
| 80050 | General health panel | <1% | 257 | $9K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 432 | $9K |
| 80061 | Lipid panel | <1% | 646 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 647 | $8K |
| 97162 | <1% | 155 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 193 | $7K |
| 83880 | <1% | 357 | $7K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 194 | $7K |
| 93971 | <1% | 104 | $7K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 272 | $6K |
| 83690 | <1% | 1,737 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 92 | $6K |
| 77066 | Tomosynthesis, mammo | <1% | 73 | $6K |
| 84702 | <1% | 343 | $6K | |
| 81001 | <1% | 2,587 | $6K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 20 | $5K |
| 81003 | <1% | 2,283 | $5K | |
| 85610 | <1% | 1,773 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 707 | $5K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 92 | $5K |
| 73564 | <1% | 228 | $4K | |
| 71250 | <1% | 82 | $4K | |
| 83735 | <1% | 945 | $4K | |
| 73610 | <1% | 206 | $3K | |
| 76536 | <1% | 74 | $3K | |
| 73630 | <1% | 287 | $3K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 86 | $3K |
| 83605 | <1% | 617 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 448 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,214 | $3K |
| 85730 | <1% | 404 | $2K | |
| 73130 | <1% | 206 | $2K | |
| 85379 | <1% | 246 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 53 | $2K |
| 76830 | Ultrasound, transvaginal | <1% | 44 | $2K |
| 94729 | <1% | 62 | $2K | |
| 86850 | <1% | 291 | $2K | |
| 85027 | <1% | 285 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 270 | $2K |
| 87040 | <1% | 138 | $2K | |
| 87631 | <1% | 14 | $2K | |
| 73030 | <1% | 123 | $2K | |
| 93970 | <1% | 13 | $1K | |
| 84439 | <1% | 169 | $1K | |
| 82803 | <1% | 59 | $1K | |
| 82947 | <1% | 367 | $1K | |
| 73110 | <1% | 99 | $1K | |
| 86900 | <1% | 326 | $1K | |
| 86901 | <1% | 326 | $1K | |
| 90715 | <1% | 57 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,443 | $953.74 |
| 70486 | <1% | 14 | $814.11 | |
| 72110 | <1% | 39 | $769.06 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 842 | $768.31 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 491 | $678.10 |
| 86618 | <1% | 26 | $669.17 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 74 | $645.23 |
| 85652 | <1% | 210 | $545.38 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,011 | $533.45 |
| 74018 | <1% | 52 | $506.01 | |
| 82607 | <1% | 38 | $475.03 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 565 | $474.78 |
| 82550 | <1% | 88 | $473.47 | |
| 94726 | <1% | 18 | $455.87 | |
| 86140 | <1% | 171 | $452.44 | |
| 86803 | <1% | 25 | $436.46 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,505 | $404.30 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 34 | $401.25 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $386.53 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,035 | $379.78 |
| 82962 | <1% | 218 | $364.35 | |
| 87077 | <1% | 63 | $350.41 | |
| 83540 | <1% | 38 | $325.12 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,283 | $281.67 |
| 72050 | <1% | 14 | $281.63 | |
| 87186 | <1% | 54 | $268.88 | |
| 73502 | <1% | 13 | $251.78 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 701 | $239.45 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 724 | $229.32 |
| 82570 | <1% | 33 | $200.48 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 378 | $190.72 |
| 86038 | <1% | 12 | $179.70 | |
| 83655 | <1% | 13 | $150.10 | |
| 82728 | <1% | 14 | $148.60 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,086 | $144.75 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 24 | $139.60 |
| 84550 | <1% | 26 | $131.20 | |
| 94010 | <1% | 13 | $91.14 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,526 | $74.90 |
| 96368 | <1% | 12 | $70.12 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 147 | $53.12 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 99 | $48.04 |
| 96376 | <1% | 14 | $31.50 | |
| A9270 | Non-covered item or service | <1% | 2,608 | $26.85 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 83 | $25.37 |
| J2704 | Injection, propofol, 10 mg | <1% | 17 | $13.20 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 97 | $9.03 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 298 | $8.78 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 48 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 13 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 38 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 184 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 12 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 14 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 13 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMAS, ROBERT (REGIONAL CFO)
| Provider | Location | Paid |
|---|---|---|
| Millennium Health, LLC | San Diego, CA | $579.29M |
| Lehigh Valley Hospital | Allentown, PA | $64.40M |
| Lehigh Valley Hospital Pocono | East Stroudsburg, PA | $11.90M |
| Lehigh Valley Hospital Hazleton | Hazleton, PA | $11.69M |
| Lehigh Valley Hospital | Allentown, PA | $10.00M |
| Lehigh Valley Hospital- Pocono | Dickson City, PA | $3.75M |
| Lehigh Valley Hospital | Allentown, PA | $2.90M |
| Lehigh Valley Hospital | Allentown, PA | $1.95M |
| Lehigh Valley Hospital, INC | Allentown, PA | $1.85M |
| Lehigh Valley Hospital | Allentown, PA | $1.40M |
| Lehigh Valley Hospital - Schuylkill | Saint Clair, PA | $744K |
| Maryland Wound & Amputation Prevention, LLC | Lutherville, MD | $399K |
| Robert L Thomas MD FCCP LLC | Walterboro, SC | $253K |
| A-One Home Health Services, LLC | Everett, WA | $236K |
| Avamere Home Health Care, LLC | Bellingham, WA | $234K |
| Lehigh Valley Hospital Schuylkill | Pottsville, PA | $218K |
| Lehigh Valley Hospital Hazleton | Hazleton, PA | $193K |
| Prime Home Health, LLC | Federal Way, WA | $115K |
| Lehigh Valley Hospital | Allentown, PA | $70K |
| Northwest Hospice LLC | Tigard, OR | $33K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.